Splitomicin is a specific Sir2p (NAD+-dependent histone deacetylase) inhibitor with an IC50 of 60 µM. This cell-active small molecule is a valuable research tool for studying chromatin biology, epigenetic regulation, and aging-related pathways in both in vitro and in vivo experimental models.